Checking IOVA unusual options activity helps you spot when traders are making outsized bets on Iovance Biotherapeutics Inc before the broader market catches on. Iovance Biotherapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor IOVA unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching IOVA unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking IOVA unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and IOVA unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc.
has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
Catalysts rarely arrive without a footprint, and IOVA unusual options activity is often where that footprint shows up first. Our scanner tracks Iovance Biotherapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at IOVA unusual options volume on the call side or chasing put sweeps, Iovance Biotherapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
